Literature DB >> 26236548

Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?

Ahmed H Abdelhafiz1, Alan J Sinclair2.   

Abstract

Diabetes mellitus is increasingly becoming an older person disease due to the increased survival and aging of the population. Previous studies which showed benefits of tight glycemic control and a linear relationship between HbA1c and mortality have largely included younger patients newly diagnosed with diabetes and with less comorbidities. Recent studies, which included older population with diabetes, have shown a U-shaped relationship of increased mortality associated with low HbA1c. The mechanism of such relationship is unclear. There was no direct causal link between low HbA1c and mortality. It appears that malnutrition, inflammation and functional decline are characteristics shared by the populations that showed increased mortality and low HbA1c. In these studies functional status, disability or frailty was not routinely measured. Therefore, although adjustment for comorbidities was made there may be a residual confounding by unmeasured factors such as frailty. Thus, frailty or decline in functional reserve may be the main confounding factor explaining the relationship between increased mortality risk and low HbA1c.

Entities:  

Keywords:  Diabetes; Frailty; Low HbA1c; Mortality

Year:  2015        PMID: 26236548      PMCID: PMC4509475          DOI: 10.14336/AD.2014.1022

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  54 in total

1.  Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people.

Authors:  R E Hubbard; M K Andrew; N Fallah; K Rockwood
Journal:  Diabet Med       Date:  2010-05       Impact factor: 4.359

Review 2.  Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults.

Authors:  Jeremy Walston; Evan C Hadley; Luigi Ferrucci; Jack M Guralnik; Anne B Newman; Stephanie A Studenski; William B Ershler; Tamara Harris; Linda P Fried
Journal:  J Am Geriatr Soc       Date:  2006-06       Impact factor: 5.562

3.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

4.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Authors:  Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

Review 5.  Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis.

Authors:  Atsushi Goto; Onyebuchi A Arah; Maki Goto; Yasuo Terauchi; Mitsuhiko Noda
Journal:  BMJ       Date:  2013-07-29

6.  Frailty status and altered glucose-insulin dynamics.

Authors:  Rita Rastogi Kalyani; Ravi Varadhan; Carlos O Weiss; Linda P Fried; Anne R Cappola
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-26       Impact factor: 6.053

7.  Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.

Authors:  Sheldon Greenfield; John Billimek; Fabio Pellegrini; Monica Franciosi; Giorgia De Berardis; Antonio Nicolucci; Sherrie H Kaplan
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

8.  Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).

Authors:  Tae Nyun Kim; Man Sik Park; Sae Jeong Yang; Hye Jin Yoo; Hyun Joo Kang; Wook Song; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

9.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

10.  Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006.

Authors:  Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  14 in total

1.  Clinical and biological markers of premature aging after autologous SCT in childhood cancer.

Authors:  A Vatanen; M Hou; T Huang; O Söder; T Jahnukainen; M Kurimo; T H Ojala; T Sarkola; M Turanlahti; U M Saarinen-Pihkala; K Jahnukainen
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

2.  The Role of Uric Acid for Predicting Future Metabolic Syndrome and Type 2 Diabetes in Older People.

Authors:  J-B Chang; Y-L Chen; Y-J Hung; C-H Hsieh; C-H Lee; D Pei; J-D Lin; C-Z Wu; Y-J Liang; C-M Lin
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus.

Authors:  Oliver Brown; Pierluigi Costanzo; Andrew L Clark; Gianluigi Condorelli; John G F Cleland; Thozhukat Sathyapalan; David Hepburn; Eric S Kilpatrick; Stephen L Atkin
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-25

Review 4.  Type 2 diabetes mellitus in older adults: clinical considerations and management.

Authors:  Srikanth Bellary; Ioannis Kyrou; James E Brown; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2021-06-25       Impact factor: 43.330

Review 5.  The effect of frailty should be considered in the management plan of older people with Type 2 diabetes.

Authors:  Ahmed H Abdelhafiz; Luan Koay; Alan J Sinclair
Journal:  Future Sci OA       Date:  2016-02-12

6.  Low glycated hemoglobin level is associated with severity of frailty in Japanese elderly diabetes patients.

Authors:  Ikumi Yanagita; Yuya Fujihara; Terumi Eda; Misuzu Tajima; Kazue Yonemura; Tomoko Kawajiri; Noriko Yamaguchi; Hideko Asakawa; Yukiko Nei; Yumi Kayashima; Mihoko Yoshimoto; Yuichi Kitajima; Mayumi Harada; Yuhei Araki; Syoji Yoshimoto; Eiji Aida; Toshihiko Yanase; Hajime Nawata; Kazuo Muta
Journal:  J Diabetes Investig       Date:  2017-07-23       Impact factor: 4.232

7.  Chronic administration of atorvastatin could partially ameliorate erectile function in streptozotocin-induced diabetic rats.

Authors:  Juhyun Park; Oh Seong Kwon; Sung Yong Cho; Jae-Seung Paick; Soo Woong Kim
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

8.  Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease.

Authors:  Jinnie J Rhee; Victoria Y Ding; David H Rehkopf; Cristina M Arce; Wolfgang C Winkelmayer
Journal:  BMC Nephrol       Date:  2015-12-09       Impact factor: 2.388

9.  Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.

Authors:  Jason I Chiang; Peter Hanlon; Tsai-Chung Li; Bhautesh Dinesh Jani; Jo-Anne Manski-Nankervis; John Furler; Cheng-Chieh Lin; Shing-Yu Yang; Barbara I Nicholl; Sharmala Thuraisingam; Frances S Mair
Journal:  PLoS Med       Date:  2020-05-07       Impact factor: 11.069

10.  Low serum albumin, aspartate aminotransferase, and body mass are risk factors for frailty in elderly people with diabetes-a cross-sectional study.

Authors:  Ikumi Yanagita; Yuya Fujihara; Chikayo Iwaya; Yuichi Kitajima; Misuzu Tajima; Masanao Honda; Yuji Teruya; Hideko Asakawa; Tomoko Ito; Terumi Eda; Noriko Yamaguchi; Yumi Kayashima; Mihoko Yoshimoto; Mayumi Harada; Shoji Yoshimoto; Eiji Aida; Toshihiko Yanase; Hajime Nawata; Kazuo Muta
Journal:  BMC Geriatr       Date:  2020-06-09       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.